No Data
No Data
Luoxin Pharmaceuticals Group Stock Co., Ltd.'s (SZSE:002793) Biggest Owners Are Individual Investors Who Got Richer After Stock Soared 11% Last Week
Key Insights Luoxin Pharmaceuticals Group Stock's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 9 invest
Luoxin Pharmaceutical (002793.SZ): Net loss of 366.616 million yuan in the first quarter
Gelonghui, April 26 | Luoxin Pharmaceutical (002793.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 689 million yuan, up 3.97% year on year; net profit attributable to shareholders of listed companies - 366.616 million yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - 389.5599 million yuan; basic earnings per share - 0.03 yuan.
Luo Xin Holdings, the controlling shareholder of Luoxin Pharmaceutical (002793.SZ), received an administrative penalty decision from the Zhejiang Securities Regulatory Bureau
According to the Zhitong Finance App, Luoxin Pharmaceutical (002793.SZ) announced that Shandong Luoxin Holdings Co., Ltd. (“Luoxin Holdings”), the controlling shareholder of the company, has received the “Administrative Penalty Decision” issued by the Zhejiang Regulatory Bureau of the China Securities Regulatory Commission. According to the decision, Luo Xin Holdings, as the shareholder of Luoxin Pharmaceutical Holdings, held 31.23% of Luoxin Pharmaceutical's shares as of May 17, 2023. From May 18 to 24, 2023, Luoxin Holdings reduced its holdings of Luoxin Pharmaceutical shares by a total of 62.25 million shares through a major transaction, accounting for 5.72% of Luoxin Pharmaceutical's total share capital. Luo Xin Holdings's total holdings reduction ratio reached
Luo Xin Holdings, the controlling shareholder of Luoxin Pharmaceutical (002793.SZ), received an advance notice of administrative penalties from the Zhejiang Securities Regulatory Bureau
Luo Xin Pharmaceutical (002793.SZ) announced that Luo Xin Holdings, the controlling shareholder of the company, recently received Zhejiang supervision from the China Securities Regulatory Commission...
Luoxin Pharmaceuticals Group Stock Co., Ltd.'s (SZSE:002793) 29% Share Price Surge Not Quite Adding Up
Luoxin Pharmaceuticals Group Stock Co., Ltd. (SZSE:002793) shareholders are no doubt pleased to see that the share price has bounced 29% in the last month, although it is still struggling to make up r
Luoxin Pharma Gets Right to Use Shenzhen Shishijijun Biotechnology's Fecal Microbiota Transplant Technology
Luoxin Pharmaceuticals Group (SHE:002793) agreed to receive the right to use Shenzhen Shishijijun Biotechnology's fecal microbiota transplant technology, according to a Thursday disclosure published o
No Data